Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

10 Apr 2006 07:00

Embargoed Release: 07:00hrs Monday 10th April 2006 Sopheon Plc (`Sopheon') Campina Chooses Sopheon System to Enhance Global Innovation Processes European Dairy Foods Leader Persuaded by Accolade's Superior Functionality and StrongCustomer Endorsements Sopheon, the international software and services company, announced today thatCampina, one of Europe's leading dairy companies and a prominent player in theglobal dairy industry, has selected Sopheon's Accolade product innovationprocess and portfolio management system to support the enhancement of itsinnovation processes. The enterprise-wide deployment will provide access tousers in 20 countries in Europe, Asia and North America.Campina's aim is to achieve international growth by offering innovative dairyproducts in Europe and Asia while maintaining leading market positionsworld-wide for specific dairy ingredients. It faces a challenge common totoday's food companies: satisfying consumer demand for a constant flow of new,appetizing and high-quality products at the lowest price. Campina'sresearch-and-development efforts are concentrated in three centers located inThe Netherlands. Consumer products for the German and Dutch markets aredeveloped by the Campina Innovation international development center atWageningen. The company produces desserts, yogurt, cheese, butter and a varietyof other consumer and industrial products under brand names such as Campina,Landliebe, Yogho Yogho and Mona, a leading line of dairy treats.One of the central elements of Campina's growth strategy is a sustained focuson innovation. The company recently developed a plan for introducing enhanced,uniform innovation processes and capabilities that would displace a mix oflegacy product-development systems being used by its various operating groups.The initiative included finding a technology solution that could reduce theadministrative workload associated with product-development process executionwhile helping to lower product-development project costs, acceleratetime-to-market and increase success rates for new products.The technology selection process centered on a detailed review of ten productlifecycle management solutions. Campina's choice of Sopheon's Accolade systemwas based primarily on the software's superior ease-of-use, its out-of-the-boxsupport for stage gate process methodology, and the speed with which it couldbe implemented. Another important Accolade advantage was its ability tointegrate with information tools already in use throughout the company, such asMicrosoft and SAP technologies and Campina's own timesheet system. Campina'sdecision was also impacted by the strength of endorsements from companies thathad implemented the Sopheon solution."Innovation is a strategic pillar of Campina's business success," said MichaelErdl, director of research and development for consumer products at Campina."We can't afford to risk the critical processes that underpin our innovationefforts on an unproven or functionally limited support system. One of thethings that really separated Sopheon from other suppliers was the enthusiastic,compelling testimonials we heard from Accolade users. We spoke with top foodcompanies who told us about the important contributions Accolade had made toadvancing their processes and productivity. The experiences these users sharedconvinced us that Accolade was a high-value solution that could play a majorrole in helping Campina reach its innovation goals.""Strong, differentiating features and functionality have been the cornerstoneof Accolade's broad market acceptance," said Nigel Cordery, European directorfor Sopheon. "But customer references are our most powerful competitiveadvantage. The willingness of Accolade users to tell prospects about themeasurable benefits of implementing our software is a principal reason thenumber of Accolade clients grew by 30% in 2005. Best of all, the solution'sconsistent performance assures new adopters that they will achieve the samekind of positive results. We're delighted to have Campina, one of the leadinginnovators in its industry, join the ranks of Accolade users."Sopheon Accolade‚® is a registered trademark of Sopheon plc.Campina, Landliebe, Yogho Yogho and Mona are registered trademarks of Campina.All other trademarks and registered trademarks are the soleproperty of their respective owners.About CampinaCampina is an international co-operative company active in the development,production, sale and distribution of dairy and dairy-related consumer productsand advanced ingredients for the food and pharmaceutical industries. Campinahas an annual turnover of around ¢â€š¬3.6 billion and some 6,800 employees. Thecompany holds leading positions in the markets in which it operates. For moreinformation, please visit www.campina.com.About SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. TheSopheon Accolade‚® product innovation process and portfolio management systemautomates gate- or phase-based product development processes and providesstrategic decision support that allows companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com. # # # For further information contact:Arif Karimjee, CFO Sopheon plc Tel : + 44 (0) 1483 685 735 Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010ENDSOPHEON PLC
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.